Srs Capital Advisors, Inc. Bridge Bio Pharma, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 51 shares of BBIO stock, worth $1,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51Holding current value
$1,264% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$770 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$623 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$349 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$309 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$150 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.68B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...